Related Experiment Video
Updated: Aug 26, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Record linkage based patient intersection cardinality for rare disease studies using Mainzelliste and secure
Tobias Kussel1,2,3, Torben Brenner4,5, Galina Tremper4,5
1Technische Universität Darmstadt, Schnittspahnstraße 10, 64287, Darmstadt, Germany. kussel@bio.tu-darmstadt.de.
Rare disease research is challenging due to fragmented patient data. Mainzelliste Secure EpiLinker (MainSEL) enables privacy-preserving record linkage for accurate patient counts between institutions, improving study feasibility.
Area of Science:
- Medical Informatics
- Computational Biology
- Epidemiology
Background:
- Rare disease research faces challenges due to fragmented patient data across multiple institutions.
- Legal and technical barriers hinder data sharing and joint analysis of sensitive medical records.
- Existing solutions often lack robust privacy guarantees or are difficult to implement.
Purpose of the Study:
- To develop and evaluate the Mainzelliste Secure EpiLinker (MainSEL) for privacy-preserving record linkage.
- To enable secure calculation of common patients between institutions for feasibility studies.
- To facilitate data consolidation and rare disease research through enhanced security and usability.
Main Methods:
- Utilized a secure Multi-Party Computation (MPC) based application with trusted-third-party-less cryptographic protocols.
- Extended MainSEL to perform record linkage for calculating the number of common patients.
- Employed microservice containerization and CI/CD for easy software deployment.
- Conducted real-world testing with medical researchers using synthetic patient data.
Main Results:
- MainSEL demonstrated practical runtimes, processing 10,000 comparisons in approximately 5 minutes.
- The framework proved feasible across diverse network settings and use cases.
- Real-world testing highlighted the need for explicit support for analysis pipeline integration and ad-hoc analysis.
Conclusions:
- MainSEL is a valuable tool for rare disease and general medical research, offering practical runtimes and enhanced security.
- The software is easily deployable in strict clinical IT environments.
- MainSEL's design, informed by real-world testing, aims to meet diverse researcher needs using modern privacy-preserving technologies.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Ligand Binding and Linkage
Sex-linked Disorders
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...

